查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
歐洲合成激素市場：依產品類型、給藥途徑、用途、最終用戶和國家進行分析和預測（2023-2033）
市場調查報告書
商品編碼
1501636

歐洲合成激素市場：依產品類型、給藥途徑、用途、最終用戶和國家進行分析和預測（2023-2033）

Europe Synthetic Hormones Market: Focus on Product Type, Route of Administration, Application, End User, and Country - Analysis and Forecast, 2023-2033
出版日期: | 出版商: BIS Research | 英文 67 Pages | 商品交期: 1-5個工作天內

價格

歐洲合成荷爾蒙市場規模預計將從 2023 年的 49 億美元成長到 2033 年的 105.3 億美元，預測期內複合年成長率為 7.94%。

隨著參與者開發創新的合成激素，合成激素市場正在不斷成長。

主要市場統計數據
預測期 2023-2033
2023年評估 49億美元
2033年預測 105.3億美元
複合年成長率 7.94%

歐洲合成荷爾蒙市場的特點是積極的研發活動，旨在推進治療方法和藥物。該地區領先的製藥公司正在積極致力於創新合成激素的開發和商業化，以解決各種醫療狀況。該市場的推動因素包括醫療保健成本不斷上升、甲狀腺功能障礙和荷爾蒙相關癌症等荷爾蒙疾病的盛行率不斷上升，以及醫療保健專業人員和患者對先進治療方案的認知不斷提高。監管支持和嚴格的品質標準也透過確保合成荷爾蒙產品的安全性和有效性進一步促進了市場成長。隨著生物技術和製藥科學的不斷進步，歐洲仍然是開發和採用尖端合成荷爾蒙療法的關鍵中心，為改善整個非洲大陸的患者治療效果和醫療保健進步做出了貢獻。

市場區隔

第 1 部分：依產品類型

  • 類固醇激素
  • 肽激素
  • 其他

第 2 部分：依給藥途徑

  • 皮下的
  • 口服
  • 靜脈內/肌肉內
  • 其他

第 3 部分：按應用

  • 糖尿病
  • 生長激素缺乏症
  • 避孕
  • 男性性腺功能低下症
  • 停經
  • 其他

第 4 部分：最終用戶

  • 醫院藥房
  • 零售藥房
  • 網路藥房

第 5 部分：按國家分類

  • 英國
  • 德國
  • 法國
  • 義大利
  • 西班牙
  • 其他

該報告調查了歐洲合成激素市場，並提供了有關行業趨勢、技術和專利趨勢、法律制度、市場成長促進和限制因素、市場規模趨勢和預測以及按各個細分市場和主要國家細分的主要企業。

目錄

執行摘要

第1章 市場

  • 趨勢：當前和未來的影響評估
    • 趨勢一：個人化合成荷爾蒙療法
    • 趨勢二：AI融合
  • 市場規模和成長潛力
  • 研發回顧
    • 專利公開趨勢（按國家）
    • 專利公開趨勢（按年份）
  • 監管狀況
  • 市場動態：概述
    • 市場促進因素
    • 市場限制因素
    • 市場機會

第2章 區域

  • 區域概況
  • 促進因素/抑制因素
  • 歐洲
    • 市場成長推進因素
    • 市場問題
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 其他

第3章市場：競爭基準化分析/公司簡介

  • 企業評價
    • Ferring BV
    • Novo Nordisk A/S
    • Ipsen Pharma
    • Novartis AG
    • Perrigo Company plc
    • Sanofi

第4章調查方法

Product Code: BHL2158SS

Introduction to Europe Synthetic Hormones Market

The Europe synthetic hormones market size was estimated at $4.90 billion in 2023 and is expected to reach $10.53 billion by 2033, growing at a CAGR of 7.94% during the forecast period 2023-2033. The synthetic hormones market is advancing due to significant developments anticipated from key market players focused on creating innovative synthetic hormones.

KEY MARKET STATISTICS
Forecast Period2023 - 2033
2023 Evaluation$4.90 Billion
2033 Forecast$10.53 Billion
CAGR7.94%

Market Introduction

The Europe synthetic hormones market is characterized by robust research and development activities aimed at advancing medical treatments and therapies. Key pharmaceutical companies across the region are actively engaged in developing and commercializing innovative synthetic hormones to address various medical conditions. This market is driven by increasing healthcare expenditure, rising prevalence of hormonal disorders such as thyroid dysfunction and hormone-related cancers, and growing awareness among healthcare professionals and patients about advanced treatment options. Regulatory support and stringent quality standards further bolster market growth by ensuring the safety and efficacy of synthetic hormone products. With ongoing advancements in biotechnology and pharmaceutical sciences, Europe continues to be a significant hub for the development and adoption of cutting-edge synthetic hormone therapies, contributing to improved patient outcomes and healthcare advancements across the continent.

Market Segmentation:

Segmentation 1: by Product Type

  • Steroid Hormones
  • Peptide Hormones
  • Others

Segmentation 2: by Route of Administration

  • Subcutaneous
  • Oral
  • Intravenous/Intramuscular
  • Others

Segmentation 3: by Application

  • Diabetes
  • Growth Hormone Deficiency
  • Contraception
  • Male Hypogonadism
  • Menopause
  • Others

Segmentation 4: by End User

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Segmentation 5: by Country

  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Rest-of-Europe

How can this report add value to an organization?

Workflow/Innovation Strategy: The Europe synthetic hormones market (by product type) has been segmented based on product type, including peptide hormones, steroid hormones, and others. Moreover, the study provides the reader with a detailed understanding of the different routes of administration and application.

Growth/Marketing Strategy: To foster growth in the synthetic hormones market, a dual strategy focusing on research and development for safer, more effective formulations, alongside expanding outreach through strategic partnerships and education campaigns, is essential. Emphasizing personalized medicine and leveraging digital platforms for market expansion and patient engagement can also be pivotal in driving market growth and visibility.

Competitive Strategy: Key players in the Europe synthetic hormones market have been analyzed and profiled in the study, including manufacturers involved in new product launches, acquisitions, expansions, and strategic collaborations. Moreover, a detailed competitive benchmarking of the players operating in the synthetic hormones market has been done to help the reader understand how players stack against each other, presenting a clear market landscape.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

Some prominent names in the market include:

  • Ferring B.V.
  • Novo Nordisk A/S
  • Ipsen Pharma
  • Novartis AG
  • Perrigo Company plc
  • Sanofi

Table of Contents

Executive Summary

Scope and Definition

1 Markets

  • 1.1 Trends: Current and Future Impact Assessment
    • 1.1.1 Trend 1: Personalized Synthetic Hormones Therapies
    • 1.1.2 Trend 2: Integration of Artificial Intelligence (AI)
  • 1.2 Market Footprint and Growth Potential, $Billion, 2022-2033
  • 1.3 Research and Development Review
    • 1.3.1 Patent Publishing Trend (by Country)
    • 1.3.2 Patent Publishing Trend (by Year)
  • 1.4 Regulatory Landscape
  • 1.5 Market Dynamics: Overview
    • 1.5.1 Market Drivers
    • 1.5.2 Market Restraints
    • 1.5.3 Market Opportunities

2 Regions

  • 2.1 Regional Summary
  • 2.2 Drivers and Restraints
  • 2.3 Europe
    • 2.3.1 Driving Factors for Market Growth
    • 2.3.2 Factors Challenging the Market
    • 2.3.3 U.K.
    • 2.3.4 Germany
    • 2.3.5 France
    • 2.3.6 Italy
    • 2.3.7 Spain
    • 2.3.8 Rest-of-Europe

3 Markets - Competitive Benchmarking & Company Profiles

  • 3.1 Company Assessment
    • 3.1.1 Ferring B.V.
      • 3.1.1.1 Overview
      • 3.1.1.2 Top Products
      • 3.1.1.3 Top Competitors
      • 3.1.1.4 Key Personnel
      • 3.1.1.5 Analyst View
    • 3.1.2 Novo Nordisk A/S
      • 3.1.2.1 Overview
      • 3.1.2.2 Top Products
      • 3.1.2.3 Top Competitors
      • 3.1.2.4 Key Personnel
      • 3.1.2.5 Analyst View
    • 3.1.3 Ipsen Pharma
      • 3.1.3.1 Overview
      • 3.1.3.2 Top Products
      • 3.1.3.3 Top Competitors
      • 3.1.3.4 Key Personnel
      • 3.1.3.5 Analyst View
    • 3.1.4 Novartis AG
      • 3.1.4.1 Overview
      • 3.1.4.2 Top Products
      • 3.1.4.3 Top Competitors
      • 3.1.4.4 Key Personnel
      • 3.1.4.5 Analyst View
    • 3.1.5 Perrigo Company plc
      • 3.1.5.1 Overview
      • 3.1.5.2 Top Products
      • 3.1.5.3 Top Competitors
      • 3.1.5.4 Key Personnel
      • 3.1.5.5 Analyst View
    • 3.1.6 Sanofi
      • 3.1.6.1 Overview
      • 3.1.6.2 Top Products
      • 3.1.6.3 Top Competitors
      • 3.1.6.4 Key Personnel
      • 3.1.6.5 Analyst View

4 Research Methodology

  • 4.1 Data Sources
    • 4.1.1 Primary Data Sources
    • 4.1.2 Secondary Data Sources
    • 4.1.3 Data Triangulation

List of Figures

  • Figure 1: Europe Synthetic Hormones Optimistic, Pessimistic and Realistic Growth, 2023, 2027,2033
  • Figure 2: Synthetic Hormones Market (by Region), $Billion, 2022, 2027, and 2033
  • Figure 3: Europe Synthetic Hormones Market (by Product Type), $Billion, 2022, 2027, and 2033
  • Figure 4: Europe Synthetic Hormones Market (by Route of Administration), $Billion, 2022, 2027, and 2033
  • Figure 5: Key Events to Keep Track of within Synthetic Hormones Market
  • Figure 6: Benefits of Personalized Synthetic Hormone Therapies
  • Figure 7: AI Utilization in Synthetic Hormones
  • Figure 8: Europe Synthetic Hormones Market, $Billion, 2022-2033
  • Figure 9: Patent Published (by Country), January 2020-December 2023
  • Figure 10: Patent Published (by Year), January 2020-December 2023
  • Figure 11: Impact Analysis of Market Dynamics, 2022-2033
  • Figure 12: Trends in Occurrence of Diabetes, 2001-2020
  • Figure 13: Hormonal Disorders and their Prevalence Globally, 2020
  • Figure 14: Uptake of HRT Medicines and Prescribing Rate, Europe
  • Figure 15: Examples of a Few Technological Advancements
  • Figure 16: Factors Contributing to High Developmental Costs
  • Figure 17: Cost of Synthetic Hormone Therapy
  • Figure 18: Regulatory Process for Synthetic Hormones
  • Figure 19: Indications and Applications of Synthetic Hormones
  • Figure 20: Factors Contributing to Precision Medicine for Synthetic Hormones
  • Figure 21: Strategic Initiatives, 2021-2023
  • Figure 22: Data Triangulation
  • Figure 23: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Opportunities across Regions
  • Table 3: Synthetic Hormones Market (by Region), $Billion, 2022-2033
  • Table 4: Europe Synthetic Hormones Market (by Product Type), $Billion, 2022-2033
  • Table 5: Europe Synthetic Hormones Market (by Route of Administration), $Billion, 2022-2033
  • Table 6: Europe Synthetic Hormones Market (by Application), $Billion, 2022-2033
  • Table 7: Europe Synthetic Hormones Market (by End User), $Billion, 2022-2033
  • Table 8: U.K. Synthetic Hormones Market (by Product Type), $Billion, 2022-2033
  • Table 9: U.K. Synthetic Hormones Market (by Route of Administration), $Billion, 2022-2033
  • Table 10: U.K. Synthetic Hormones Market (by Application), $Billion, 2022-2033
  • Table 11: U.K. Synthetic Hormones Market (by End User), $Billion, 2022-2033
  • Table 12: Germany Synthetic Hormones Market (by Product Type), $Billion, 2022-2033
  • Table 13: Germany Synthetic Hormones Market (by Route of Administration), $Billion, 2022-2033
  • Table 14: Germany Synthetic Hormones Market (by Application), $Billion, 2022-2033
  • Table 15: Germany Synthetic Hormones Market (by End User), $Billion, 2022-2033
  • Table 16: France Synthetic Hormones Market (by Product Type), $Billion, 2022-2033
  • Table 17: France Synthetic Hormones Market (by Route of Administration), $Billion, 2022-2033
  • Table 18: France Synthetic Hormones Market (by Application), $Billion, 2022-2033
  • Table 19: France Synthetic Hormones Market (by End User), $Billion, 2022-2033
  • Table 20: Italy Synthetic Hormones Market (by Product Type), $Billion, 2022-2033
  • Table 21: Italy Synthetic Hormones Market (by Route of Administration), $Billion, 2022-2033
  • Table 22: Italy Synthetic Hormones Market (by Application), $Billion, 2022-2033
  • Table 23: Italy Synthetic Hormones Market (by End User), $Billion, 2022-2033
  • Table 24: Spain Synthetic Hormones Market (by Product Type), $Billion, 2022-2033
  • Table 25: Spain Synthetic Hormones Market (by Route of Administration), $Billion, 2022-2033
  • Table 26: Spain Synthetic Hormones Market (by Application), $Billion, 2022-2033
  • Table 27: Spain Synthetic Hormones Market (by End User), $Billion, 2022-2033
  • Table 28: Rest-of-Europe Synthetic Hormones Market (by Product Type), $Billion, 2022-2033
  • Table 29: Rest-of-Europe Synthetic Hormones Market (by Route of Administration), $Billion, 2022-2033
  • Table 30: Rest-of-Europe Synthetic Hormones Market (by Application), $Billion, 2022-2033
  • Table 31: Rest-of-Europe Synthetic Hormones Market (by End User), $Billion, 2022-2033
  • Table 32: Market Share